Canopy Growth (CGC) Liabilities and Shareholders Equity (2017 - 2025)

Canopy Growth's (CGC) quarterly Liabilities and Shareholders Equity came in at $793.2 million in Q4 2025, up 71.31% year-on-year from $463.0 million in Q4 2024, and up 2.04% quarter-over-quarter from $777.4 million in Q3 2025.

Canopy Growth (CGC) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends

Canopy Growth has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $793.2 million for Q4 2025.

  • Liabilities and Shareholders Equity for Q4 2025 came in at $793.2 million, up 71.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 billion (down 12.49% YoY), and the FY2025 annual result was $639.6 million, down 33.72% from the prior year.
  • Liabilities and Shareholders Equity came in at $793.2 million for Q4 2025 at Canopy Growth, up from $777.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.7 billion in Q2 2021 to a low of $463.0 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $1.4 billion (2023), against an average of $2.2 billion.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 59.22% in 2023 and jumped 71.31% in 2025, its largest moves.
  • Canopy Growth's Liabilities and Shareholders Equity stood at $5.0 billion in 2021, then slumped by 56.73% to $2.2 billion in 2022, then tumbled by 53.88% to $998.8 million in 2023, then tumbled by 53.64% to $463.0 million in 2024, then surged by 71.31% to $793.2 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $793.2 million (Q4 2025), $777.4 million (Q3 2025), and $652.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Canopy Growth 11.38 Mn -137.31 Mn 15.39 Mn 793.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 793.24 Mn
Sep 30, 2025 777.38 Mn
Jun 30, 2025 652.91 Mn
Mar 31, 2025 639.56 Mn
Dec 31, 2024 463.04 Mn
Sep 30, 2024 903.38 Mn
Jun 30, 2024 940.41 Mn
Mar 31, 2024 964.99 Mn
Dec 31, 2023 998.79 Mn
Sep 30, 2023 1.24 Bn
Jun 30, 2023 1.63 Bn
Mar 31, 2023 1.80 Bn
Dec 31, 2022 2.17 Bn
Sep 30, 2022 2.55 Bn
Jun 30, 2022 2.75 Bn
Mar 31, 2022 4.43 Bn
Dec 31, 2021 5.01 Bn
Sep 30, 2021 5.16 Bn
Jun 30, 2021 5.67 Bn
Mar 31, 2021 5.39 Bn